Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Chronic Renal Failure

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    April 2020
  1. GAUDRY S, Hajage D, Benichou N, Chaibi K, et al
    Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30531.
    PubMed     Abstract available


  2. NIEUWENHUIJS-MOEKE GJ, Sanders JSF
    Timing of renal replacement therapy in acute kidney injury: case closed?
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30805.
    PubMed    


    February 2020

  3. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2020 Feb 13. pii: S0140-6736(20)30045.
    PubMed     Abstract available


  4. COCKWELL P, Fisher LA
    The global burden of chronic kidney disease.
    Lancet. 2020 Feb 13. pii: S0140-6736(19)32977.
    PubMed    


    January 2020
  5. HEERSPINK HJL, Parving HH, de Zeeuw D
    Atrasentan in patients with diabetes and chronic kidney disease - Authors' reply.
    Lancet. 2020;395:270.
    PubMed    


  6. SEPE V, Libetta C
    Atrasentan in patients with diabetes and chronic kidney disease.
    Lancet. 2020;395:269.
    PubMed    


  7. LIU D, Liu Z
    Atrasentan in patients with diabetes and chronic kidney disease.
    Lancet. 2020;395:269-270.
    PubMed    


    November 2019
  8. MORATH C, Zschiedrich S, Speer C, Zeier M, et al
    Clinical outcomes after ABO-incompatible renal transplantation.
    Lancet. 2019;394:1989.
    PubMed    


  9. SCURT FG, Mertens PR, Chatzikyrkou C
    Clinical outcomes after ABO-incompatible renal transplantation - Authors' reply.
    Lancet. 2019;394:1989-1990.
    PubMed    


  10. LOUPY A, Bouquegneau A, Stegall MD, Montgomery RA, et al
    Clinical outcomes after ABO-incompatible renal transplantation.
    Lancet. 2019;394:1988-1989.
    PubMed    


    September 2019
  11. AGARWAL R, Rossignol P, Romero A, Garza D, et al
    Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2019 Sep 13. pii: S0140-6736(19)32135.
    PubMed     Abstract available


    June 2019
  12. WESSON DE, Mathur V, Tangri N, Stasiv Y, et al
    Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
    Lancet. 2019 Jun 24. pii: S0140-6736(19)31388.
    PubMed     Abstract available


    April 2019
  13. CURRIE IS, Henderson LK
    ABO-incompatible renal transplantation.
    Lancet. 2019 Apr 18. pii: S0140-6736(19)30296.
    PubMed    


  14. SCURT FG, Ewert L, Mertens PR, Haller H, et al
    Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis.
    Lancet. 2019 Apr 18. pii: S0140-6736(18)32091.
    PubMed     Abstract available


  15. PAN D, Arkell P, Stone NRH, Parkinson B, et al
    Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids.
    Lancet. 2019;393:1536.
    PubMed    


  16. TUTTLE KR
    A turning point for chronic kidney disease in diabetes.
    Lancet. 2019 Apr 12. pii: S0140-6736(19)30855.
    PubMed    


  17. HEERSPINK HJL, Parving HH, Andress DL, Bakris G, et al
    Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
    Lancet. 2019 Apr 12. pii: S0140-6736(19)30772.
    PubMed     Abstract available


    March 2019
  18. WESSON DE, Mathur V, Tangri N, Stasiv Y, et al
    Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32562.
    PubMed     Abstract available


    February 2019
  19. JORDAN SC
    Immune response to non-HLA antigens and renal allograft loss.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)33186.
    PubMed    


    January 2017
  20. MANOOK M, Koeser L, Ahmed Z, Robb M, et al
    Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis.
    Lancet. 2017 Jan 5. pii: S0140-6736(16)31595.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: